Transgene Biotek Ltd — Others, 25-07-2025: Others

Transgene Biotek Limited has clarified its compliance status, informing stakeholders that specific reporting requirements for non-convertible securities do not apply to the company. This is because the company has not issued any non-convertible securities. As a result, there are no obligations for interest, dividend, or principal payments on such instruments, nor any unpaid dues to report. This streamlines the company's compliance filings and provides clarity on its financial structure, indicating no outstanding non-convertible debt.